Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Antibody Conjugation of a Chimeric BET Degrader Enables In Vivo Activity.

Pillow TH, Adhikari P, Blake RA, Chen J, Del Rosario G, Deshmukh G, Figueroa I, Gascoigne KE, Kamath AV, Kaufman S, Kleinheinz T, Kozak KR, Latifi B, Leipold DD, Li CS, Li R, Mulvihill MM, O'Donohue A, Rowntree RK, Sadowsky JD, Wai J, Wang X, Wu C, Xu Z, Yao H, Yu SF, Zhang D, Zang R, Zhang H, Zhou H, Zhu X, Dragovich P.

ChemMedChem. 2019 Oct 31. doi: 10.1002/cmdc.201900497. [Epub ahead of print]

PMID:
31674143
2.

Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients.

Ezekian B, Schroder PM, Mulvihill MS, Barbas A, Collins B, Freischlag K, Yoon J, Yi JS, Smith F, Olaso D, Saccoccio FM, Permar S, Farris AB, Kwun J, Knechtle SJ.

J Am Soc Nephrol. 2019 Oct 28. pii: ASN.2019030304. doi: 10.1681/ASN.2019030304. [Epub ahead of print]

PMID:
31658991
3.

Single lung transplantation in patients with severe secondary pulmonary hypertension.

Nasir BS, Mulvihill MS, Barac YD, Bishawi M, Cox ML, Megna DJ, Haney JC, Klapper JA, Daneshmand MA, Hartwig MG.

J Heart Lung Transplant. 2019 Sep;38(9):939-948. doi: 10.1016/j.healun.2019.06.014. Epub 2019 Jul 4.

PMID:
31495410
4.

FAILURE TO RESCUE CONTRIBUTES TO CENTER-LEVEL DIFFERENCES IN MORTALITY AFTER LUNG TRANSPLANTATION.

Osho AA, Bishawi MM, Mulvihill MS, Axtell AL, Hirji SA, Spencer PJ, Heng EE, D'Alessandro DA, Melnitchouk S, Hartwig MG, Villavicencio MA.

Ann Thorac Surg. 2019 Aug 27. pii: S0003-4975(19)31230-5. doi: 10.1016/j.athoracsur.2019.07.013. [Epub ahead of print]

PMID:
31470009
5.

Impact of Donor Brain Death Duration on Outcomes After Lung Transplantation.

Jawitz OK, Raman V, Barac Y, Mulvihill MS, Moore C, Choi AY, Hartwig M, Klapper J.

Ann Thorac Surg. 2019 Nov;108(5):1519-1526. doi: 10.1016/j.athoracsur.2019.05.026. Epub 2019 Jul 2.

PMID:
31271742
6.

The role of human CD46 in early xenoislet engraftment in a dual transplant model.

Samy KP, Gao Q, Davis RP, Song M, Fitch ZW, Mulvihill MS, MacDonald AL, Leopardi FV, How T, Williams KD, Devi GR, Collins BH, Luo X, Kirk AD.

Xenotransplantation. 2019 Jun 20:e12540. doi: 10.1111/xen.12540. [Epub ahead of print]

PMID:
31219218
7.

Challenging 30-day mortality as a site-specific quality metric in non-small cell lung cancer.

Moore CB, Cox ML, Mulvihill MS, Klapper J, D'Amico TA, Hartwig MG.

J Thorac Cardiovasc Surg. 2019 Aug;158(2):570-578.e3. doi: 10.1016/j.jtcvs.2019.02.123. Epub 2019 Mar 28.

PMID:
31056356
8.

Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study.

Mulvihill MS, Samy KP, Gao QA, Schmitz R, Davis RP, Ezekian B, Leopardi F, Song M, How T, Williams K, Barbas A, Collins B, Kirk AD.

Am J Transplant. 2019 Aug;19(8):2350-2357. doi: 10.1111/ajt.15365. Epub 2019 Apr 12.

PMID:
30891931
9.

Endoscopic cyclophotocoagulation (ECP) for childhood glaucoma: a large single-center cohort experience.

Glaser TS, Mulvihill MS, Freedman SF.

J AAPOS. 2019 Apr;23(2):84.e1-84.e7. doi: 10.1016/j.jaapos.2018.10.014. Epub 2019 Mar 16.

PMID:
30890461
10.

Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation.

Cox ML, Mulvihill MS, Choi AY, Bishawi M, Osho AA, Haney JC, Daneshmand M, Klapper JA, Wolfe CR, Hartwig M.

J Heart Lung Transplant. 2019 Mar;38(3):295-305. doi: 10.1016/j.healun.2018.12.012. Epub 2018 Dec 21.

PMID:
30773195
11.

Elevated Donor Hemoglobin A1C Impairs Kidney Graft Survival From Deceased Donors With Diabetes Mellitus: A National Analysis.

Bendersky VA, Mulvihill MS, Yerokun BA, Ezekian B, Davis RP, Hartwig MG, Barbas AS.

Exp Clin Transplant. 2019 Oct;17(5):613-618. doi: 10.6002/ect.2017.0322. Epub 2019 Jan 21.

12.

Simultaneous Versus Sequential Heart-liver Transplantation: Ideal Strategies for Organ Allocation.

Rucker AJ, Anderson KL, Mulvihill MS, Yerokun BA, Barbas AS, Hartwig MG.

Transplant Direct. 2018 Dec 19;5(1):e415. doi: 10.1097/TXD.0000000000000854. eCollection 2019 Jan.

13.

Early experience with the use of hepatitis C antibody-positive, nucleic acid testing-negative donors in lung transplantation.

Watson J, Mulvihill MS, Cox ML, Rich L, Wolfe CR, Gray A, Hartwig MG.

Clin Transplant. 2019 Mar;33(3):e13476. doi: 10.1111/ctr.13476. Epub 2019 Feb 8.

PMID:
30609162
14.

Transdermal Delivery of Enfuvirtide in a Porcine Model Using a Low-Frequency, Low-Power Ultrasound Transducer Patch.

Snook KA, Van Ess R 2nd, Werner JR, Clement RS, Ocon-Grove OM, Dodds JW, Ryan KJ, Acosta EP, Zurlo JJ, Mulvihill ML.

Ultrasound Med Biol. 2019 Feb;45(2):513-525. doi: 10.1016/j.ultrasmedbio.2018.10.003. Epub 2018 Dec 21.

PMID:
30583819
15.

Quantitative Determination of Protein-Ligand Affinity by Size Exclusion Chromatography Directly Coupled to High-Resolution Native Mass Spectrometry.

Ren C, Bailey AO, VanderPorten E, Oh A, Phung W, Mulvihill MM, Harris SF, Liu Y, Han G, Sandoval W.

Anal Chem. 2019 Jan 2;91(1):903-911. doi: 10.1021/acs.analchem.8b03829. Epub 2018 Dec 12.

PMID:
30481450
16.

A Propensity-matched Survival Analysis: Do Simultaneous Liver-lung Transplant Recipients Need a Liver?

Freischlag K, Ezekian B, Schroder PM, Mulvihill MS, Cox ML, Hartwig MG, Knechtle S.

Transplantation. 2019 Aug;103(8):1675-1682. doi: 10.1097/TP.0000000000002529.

PMID:
30444805
17.

Decline of Increased Risk Donor Offers on Waitlist Survival in Heart Transplantation.

Mulvihill MS, Cox ML, Bishawi M, Osho AA, Yerokun BA, Wolfe CR, DeVore AD, Patel CB, Hartwig MG, Milano CA, Schroder JN.

J Am Coll Cardiol. 2018 Nov 6;72(19):2408-2409. doi: 10.1016/j.jacc.2018.07.097. No abstract available.

18.

Implications of blood group on lung transplantation rates: A propensity-matched registry analysis.

Barac YD, Mulvihill MS, Cox ML, Bishawi M, Klapper J, Haney J, Daneshmand M, Hartwig MG.

J Heart Lung Transplant. 2019 Jan;38(1):73-82. doi: 10.1016/j.healun.2018.09.013. Epub 2018 Sep 25.

PMID:
30366846
19.

Improved contemporary outcomes of liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma.

Ezekian B, Mulvihill MS, Schroder PM, Gilmore BF, Leraas HJ, Gulack BC, Jane Commander S, Mavis AM, Kreissman SG, Knechtle SJ, Tracy ET, Barbas AS.

Pediatr Transplant. 2018 Dec;22(8):e13305. doi: 10.1111/petr.13305. Epub 2018 Oct 19.

PMID:
30341782
20.

Improved survival in simultaneous lung-liver recipients and candidates in the modern era of lung allocation.

Freischlag K, Schroder PM, Ezekian B, Cox ML, Mulvihill MS, Hartwig MG, Knechtle SJ.

J Surg Res. 2018 Nov;231:395-402. doi: 10.1016/j.jss.2018.06.007. Epub 2018 Jun 30.

PMID:
30278959
21.

Higher Use of Surgery Confers Superior Survival in Stage I Non-Small Cell Lung Cancer.

Mulvihill MS, Cox ML, Becerra DC, Watson JA, Voigt SL, Yerokun BA, Speicher PJ, D'Amico TA, Tong B, Hartwig MG.

Ann Thorac Surg. 2018 Nov;106(5):1533-1540. doi: 10.1016/j.athoracsur.2018.05.066. Epub 2018 Jun 28.

PMID:
29959940
22.

Improvement in Liver Transplant Outcomes From Older Donors: A US National Analysis.

Gao Q, Mulvihill MS, Scheuermann U, Davis RP, Yerxa J, Yerokun BA, Hartwig MG, Sudan DL, Knechtle SJ, Barbas AS.

Ann Surg. 2019 Aug;270(2):333-339. doi: 10.1097/SLA.0000000000002876.

PMID:
29958229
23.

Single-Center Long-Term Analysis of Combined Liver-Lung Transplant Outcomes.

Freischlag KW, Messina J, Ezekian B, Mulvihill MS, Barbas A, Berg C, Sudan D, Reynolds J, Hartwig M, Knechtle S.

Transplant Direct. 2018 Apr 26;4(5):e349. doi: 10.1097/TXD.0000000000000785. eCollection 2018 May.

24.

Liver Transplantation Without Venovenous Bypass: Does Surgical Approach Matter?

Barbas AS, Levy J, Mulvihill MS, Goldaracena N, Dib MJ, Al-Adra DP, Cattral MS, Ghanekar A, Greig PD, Grant DR, Sapisochin G, Selzner M, McCluskey SA, McGilvray ID.

Transplant Direct. 2018 Apr 24;4(5):e348. doi: 10.1097/TXD.0000000000000776. eCollection 2018 May.

25.

Determination of Affinity and Residence Time of Potent Drug-Target Complexes by Label-free Biosensing.

Quinn JG, Pitts KE, Steffek M, Mulvihill MM.

J Med Chem. 2018 Jun 28;61(12):5154-5161. doi: 10.1021/acs.jmedchem.7b01829. Epub 2018 Jun 7.

PMID:
29772180
26.

Is Functional Independence Associated With Improved Long-Term Survival After Lung Transplantation?

Osho A, Mulvihill M, Lamba N, Hirji S, Yerokun B, Bishawi M, Spencer P, Panda N, Villavicencio M, Hartwig M.

Ann Thorac Surg. 2018 Jul;106(1):79-84. doi: 10.1016/j.athoracsur.2018.01.069. Epub 2018 Mar 1.

PMID:
29501640
27.

Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling.

Goncharov T, Hedayati S, Mulvihill MM, Izrael-Tomasevic A, Zobel K, Jeet S, Fedorova AV, Eidenschenk C, deVoss J, Yu K, Shaw AS, Kirkpatrick DS, Fairbrother WJ, Deshayes K, Vucic D.

Mol Cell. 2018 Feb 15;69(4):551-565.e7. doi: 10.1016/j.molcel.2018.01.016.

28.

Dilution destabilizes engineered ligand-coated nanoparticles in aqueous suspensions.

Wan J, Kim Y, Mulvihill MJ, Tokunaga TK.

Environ Toxicol Chem. 2018 May;37(5):1301-1308. doi: 10.1002/etc.4103. Epub 2018 Mar 31.

29.

Esophageal resection after neoadjuvant therapy: understanding the limitations of large database analyses.

Ranney DN, Mulvihill MS, Yerokun BA, Hartwig MG.

J Thorac Dis. 2017 Oct;9(10):E949-E950. doi: 10.21037/jtd.2017.09.13. No abstract available.

30.

Lung transplantation in the most critically-III: forging ahead.

Mulvihill MS, Hartwig MG, Daneshmand MA.

J Thorac Dis. 2017 Sep;9(9):3430-3432. doi: 10.21037/jtd.2017.08.12.

31.

Reply to Moris et al.

Ranney DN, Mulvihill MS, Yerokun BA, Hartwig MG.

Eur J Cardiothorac Surg. 2017 Nov 1;52(5):1011. doi: 10.1093/ejcts/ezx253. No abstract available.

PMID:
28977389
32.

Getting to transplantation.

Mulvihill MS, Hartwig MG.

Am J Transplant. 2018 Jan;18(1):7-8. doi: 10.1111/ajt.14482. Epub 2017 Sep 15. No abstract available.

33.

Survival after lung transplantation in recipients with alpha-1-antitrypsin deficiency compared to other forms of chronic obstructive pulmonary disease: a national cohort study.

Gulack BC, Mulvihill MS, Ganapathi AM, Speicher PJ, Chery G, Snyder LD, Davis RD, Hartwig MG.

Transpl Int. 2018 Jan;31(1):45-55. doi: 10.1111/tri.13038. Epub 2017 Sep 12.

34.

Adjuvant Chemotherapy Does Not Confer Superior Survival in Patients With Atypical Carcinoid Tumors.

Anderson KL Jr, Mulvihill MS, Speicher PJ, Yerokun BA, Gulack BC, Nussbaum DP, Harpole DH Jr, D'Amico TA, Berry MF, Hartwig MG.

Ann Thorac Surg. 2017 Oct;104(4):1221-1230. doi: 10.1016/j.athoracsur.2017.05.011. Epub 2017 Jul 29.

35.

Extracorporeal membrane oxygenation following lung transplantation: indications and survival.

Mulvihill MS, Yerokun BA, Davis RP, Ranney DN, Daneshmand MA, Hartwig MG.

J Heart Lung Transplant. 2017 Jul 1. pii: S1053-2498(17)31880-6. doi: 10.1016/j.healun.2017.06.014. [Epub ahead of print]

PMID:
28712677
36.

Extracorporeal Membrane Oxygenation and Interfacility Transfer: A Regional Referral Experience.

Ranney DN, Bonadonna D, Yerokun BA, Mulvihill MS, Al-Rawas N, Weykamp M, Gunasingha RM, Bartz RR, Haney JC, Daneshmand MA.

Ann Thorac Surg. 2017 Nov;104(5):1471-1478. doi: 10.1016/j.athoracsur.2017.04.028. Epub 2017 Jun 30.

PMID:
28673618
37.

Fatal SV40-associated pneumonia and nephropathy following renal allotransplantation in rhesus macaque.

Song M, Mulvihill MS, Williams KD, Collins BH, Kirk AD.

J Med Primatol. 2018 Feb;47(1):81-84. doi: 10.1111/jmp.12285. Epub 2017 Jul 3.

38.

Elevated HbA1c in donor organs from patients without a diagnosis of diabetes portends worse liver allograft survival.

Ezekian B, Mulvihill MS, Freischlag K, Yerokun BA, Davis RP, Hartwig MG, Knechtle SJ, Barbas AS.

Clin Transplant. 2017 Sep;31(9). doi: 10.1111/ctr.13047. Epub 2017 Jul 21.

PMID:
28667782
39.

Usefulness of 2 centrifugal ventricular assist devices in a total artificial heart configuration: A preliminary report.

Mulvihill MS, Joseph JT, Daneshmand MA, Patel CB, Milano CA, Schroder JN.

J Heart Lung Transplant. 2017 Nov;36(11):1266-1268. doi: 10.1016/j.healun.2017.05.019. Epub 2017 May 20. No abstract available.

PMID:
28666571
40.

Impact of a freeway on the dispersal of ticks and Ixodes ricinus-borne pathogens: forested resting areas may become Lyme disease hotspots.

Hornok S, Mulvihill M, Szőke K, Gönczi E, Sulyok KM, Gyuranecz M, Hofmann-Lehmann R.

Acta Vet Hung. 2017 Jun;65(2):242-252. doi: 10.1556/004.2017.024.

PMID:
28605964
41.

Surgical resection after neoadjuvant chemoradiation for oesophageal adenocarcinoma: what is the optimal timing?

Ranney DN, Mulvihill MS, Yerokun BA, Fitch Z, Sun Z, Yang CF, D'Amico TA, Hartwig MG.

Eur J Cardiothorac Surg. 2017 Sep 1;52(3):543-551. doi: 10.1093/ejcts/ezx132.

PMID:
28498967
42.

Elevated donor hemoglobin A1c does not impair early survival in cardiac transplant recipients.

Joseph JT, Mulvihill MS, Yerokun BA, Bell SM, Milano CA, Hartwig MG.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12995. Epub 2017 Jun 10.

PMID:
28470781
43.

The association of donor age and survival is independent of ischemic time following deceased donor lung transplantation.

Mulvihill MS, Gulack BC, Ganapathi AM, Speicher PJ, Englum BR, Hirji SA, Snyder LD, Davis RD, Hartwig MG.

Clin Transplant. 2017 Jul;31(7). doi: 10.1111/ctr.12993. Epub 2017 Jun 1.

44.

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non-small cell lung cancer.

Yerokun BA, Yang CJ, Gulack BC, Li X, Mulvihill MS, Gu L, Wang X, Harpole DH, D'Amico TA, Berry MF, Hartwig MG.

J Thorac Cardiovasc Surg. 2017 Aug;154(2):675-686.e4. doi: 10.1016/j.jtcvs.2017.02.065. Epub 2017 Apr 4.

45.

Induction chemotherapy for T3N0M0 non-small-cell lung cancer increases the rate of complete resection but does not confer improved survival.

Anderson KL Jr, Mulvihill MS, Yerokun BA, Speicher PJ, D'Amico TA, Tong BC, Berry MF, Hartwig MG.

Eur J Cardiothorac Surg. 2017 Aug 1;52(2):370-377. doi: 10.1093/ejcts/ezx091.

46.

Long-term survival following kidney transplantation in previous lung transplant recipients-An analysis of the unos registry.

Osho AA, Hirji SA, Castleberry AW, Mulvihill MS, Ganapathi AM, Speicher PJ, Yerokun B, Snyder LD, Davis RD, Hartwig MG.

Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12953. Epub 2017 Apr 17.

47.

Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation.

Manook M, Kwun J, Burghuber C, Samy K, Mulvihill M, Yoon J, Xu H, MacDonald AL, Freischlag K, Curfman V, Branum E, Howell D, Farris AB, Smith RA, Sacks S, Dorling A, Mamode N, Knechtle SJ.

Am J Transplant. 2017 Aug;17(8):2055-2064. doi: 10.1111/ajt.14234. Epub 2017 Mar 23. Erratum in: Am J Transplant. 2017 Nov;17 (11):2993.

48.

The utility of 6-minute walk distance in predicting waitlist mortality for lung transplant candidates.

Castleberry A, Mulvihill MS, Yerokun BA, Gulack BC, Englum B, Snyder L, Worni M, Osho A, Palmer S, Davis RD, Hartwig MG.

J Heart Lung Transplant. 2017 Jul;36(7):780-786. doi: 10.1016/j.healun.2016.12.015. Epub 2016 Dec 30.

49.

Transplant size mismatch in restrictive lung disease.

Ganapathi AM, Mulvihill MS, Englum BR, Speicher PJ, Gulack BC, Osho AA, Yerokun BA, Snyder LR, Davis D, Hartwig MG.

Transpl Int. 2017 Apr;30(4):378-387. doi: 10.1111/tri.12913.

50.

Clinical predictors and outcome implications of early readmission in lung transplant recipients.

Osho AA, Castleberry AW, Yerokun BA, Mulvihill MS, Rucker J, Snyder LD, Davis RD, Hartwig MG.

J Heart Lung Transplant. 2017 May;36(5):546-553. doi: 10.1016/j.healun.2016.11.001. Epub 2016 Nov 10.

Supplemental Content

Loading ...
Support Center